These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 20090346

  • 1. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
    Poryazova R, Benninger D, Waldvogel D, Bassetti CL.
    Eur Neurol; 2010; 63(3):129-35. PubMed ID: 20090346
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Excessive daytime sleepiness in de novo and treated Parkinson's disease.
    Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G.
    Mov Disord; 2002 Sep; 17(5):1026-30. PubMed ID: 12360553
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
    Compta Y, Santamaria J, Ratti L, Tolosa E, Iranzo A, Muñoz E, Valldeoriola F, Casamitjana R, Ríos J, Marti MJ.
    Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
    [Abstract] [Full Text] [Related]

  • 6. Sleepiness in Parkinson's disease: a controlled study.
    Brodsky MA, Godbold J, Roth T, Olanow CW.
    Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
    [Abstract] [Full Text] [Related]

  • 7. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S, Kanbayashi T.
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE, Seppi K, Cardozo A, Iranzo A, Stampfer-Kountchev M, Wenning G, Tolosa E, Högl B, Santamaria J, Poewe W, SINBAR (Sleep Innsbruck Barcelona) group.
    Mov Disord; 2007 Sep 15; 22(12):1822-4. PubMed ID: 17659646
    [Abstract] [Full Text] [Related]

  • 11. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W.
    Sleep; 2002 Dec 15; 25(8):905-9. PubMed ID: 12489899
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors.
    Seneviratne U, Puvanendran K.
    Sleep Med; 2004 Jul 15; 5(4):339-43. PubMed ID: 15222989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V, Dhoat S, Williams AJ, Dimarco A, Pal S, Forbes A, Tobías A, Martinez-Martin P, Chaudhuri KR.
    J Neurol Sci; 2006 Oct 25; 248(1-2):158-62. PubMed ID: 16780888
    [Abstract] [Full Text] [Related]

  • 18. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
    Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U.
    Mov Disord; 2003 Jun 25; 18(6):659-67. PubMed ID: 12784269
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.